Gene · 84335
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase II study of everolimus for recurrent or progressive pediatric ependymoma. | Neurooncol Adv | 2023 | 36950217 | PubTator, text mining | PubMed |
| Targeting autophagy process in center nervous trauma. | Front Neurosci | 2023 | 36950126 | PubTator, text mining | PubMed |
| Editorial: Cancer stem cells as attractive targets for breast cancer therapy. | Front Oncol | 2023 | 36937444 | PubTator, text mining | PubMed |
| A central chaperone-like role for 14-3-3 proteins in human cells. | Mol Cell | 2023 | 36931259 | PubTator, text mining | PubMed |
| Regulation of mTORC1 by the Rag GTPases. | Biochem Soc Trans | 2023 | 36929165 | PubTator, text mining | PubMed |
| Decrypting drug actions and protein modifications by dose- and time-resolved proteomics. | Science | 2023 | 36926954 | PubTator, text mining | PubMed |
| Causal relationship between insulin resistance and sarcopenia. | Diabetol Metab Syndr | 2023 | 36918975 | PubTator, text mining | PubMed |
| Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence. | EBioMedicine | 2023 | 36907105 | PubTator, text mining | PubMed |
| The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 36902280 | PubTator, text mining | PubMed |
| Phosphoinositide 3-Kinase (PI3K) Inhibitors and Breast Cancer: An Overview of Current Achievements. | Cancers (Basel) | 2023 | 36900211 | PubTator, text mining | PubMed |
| Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton's tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics. | PLoS One | 2023 | 36897912 | PubTator, text mining | PubMed |
| Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients. | J Clin Pathol | 2023 | 36894313 | PubTator, text mining | PubMed |
Inhibition of mammalian target of rapamycin complex 1 in the brain microvascular endothelium ameliorates diabetic Aβ brain deposition and cognitive impairment via the sterol-regulatory element-binding protein 1/lipoprotein receptor-associated protein 1 signaling pathway. | CNS Neurosci Ther | 2023 | 36890627 | PubTator, text mining | PubMed |
| EWSR1 prevents the induction of aneuploidy through direct regulation of Aurora B. | Front Cell Dev Biol | 2023 | 36875767 | PubTator, text mining | PubMed |
| Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers. | Front Immunol | 2023 | 36875073 | PubTator, text mining | PubMed |
TGF-β-induced PI3K/AKT/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease. | Cell Prolif | 2023 | 36869852 | PubTator, text mining | PubMed |
| Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy. | Endocr Rev | 2023 | 36869790 | PubTator, text mining | PubMed |
| Circular RNAs: implications of signaling pathways and bioinformatics in human cancer. | Cancer Biol Med | 2023 | 36861443 | PubTator, text mining | PubMed |
| The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. | Exp Mol Med | 2023 | 36854773 | PubTator, text mining | PubMed |
| ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2. | Cancer Sci | 2023 | 36851875 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84335/papers?page=13